Lonidamine (LON) (1-[(2,4-Dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid) is a hexokinase 2 inhibitor that has been shown to induce apoptosis and treat MDR in various cancer cell lines [12], [13], [14]. This evidence concerns the gene HK2 and cancer.